A. Ernest Toth Jr - Jun 15, 2021 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP, Chief Financial Officer
Signature
/s/ Lori J. Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 06:51 PM
Next filing
Mar 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (Right to Purchase) Award $0 +120K $0.00 120K Jun 15, 2021 Common Stock 120K $4.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to the Reporting Person of a stock option to purchase Common Stock of the Issuer under the Issuer's 2018 Equity Incentive Plan (the "Plan"). Said options vest over a three-year period, with 25% of such option vesting on each of the one-year and two-year anniversaries of the option vesting commencement date and the remaining 50% vesting on the third-year anniversary of the option vesting commencement date, provided that at the relevant vesting date, the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan. The option expires ten years after the date of grant.